Envista Holdings (NVST) Amortization of Deferred Charges (2019 - 2026)

Envista Holdings (NVST) recorded quarterly Amortization of Deferred Charges of $18.8 million in Q2 2026, up 135.67% quarter-over-quarter from -$52.7 million in Q4 2025, and little changed on a YoY basis from $18.8 million in Q2 2025.

Envista Holdings (NVST) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends

Envista Holdings' Amortization of Deferred Charges history runs 8 years deep, the most recent figure standing at $18.8 million for Q2 2026.

  • In Q2 2026, Amortization of Deferred Charges changed 0.0% year-over-year to $18.8 million; the TTM figure through Apr 2026 stood at -$33.1 million (up 16.83% YoY), while the FY2025 annual figure was $4.2 million, down 14.29% from the prior year.
  • Amortization of Deferred Charges was $18.8 million for Q2 2026 at Envista Holdings, up from -$52.7 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $27.9 million in Q1 2023 to a low of -$71.3 million in Q4 2023.
  • Historically, Amortization of Deferred Charges has averaged -$4.2 million across 5 years, with a median of $700000.0 in 2025.
  • The sharpest annual moves came in 2023 and 2025: Amortization of Deferred Charges tumbled 356.47% in 2023, then soared 1466.67% in 2025.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $27.8 million in 2022, then sank by 356.47% to -$71.3 million in 2023, then increased by 17.53% to -$58.8 million in 2024, then climbed by 10.37% to -$52.7 million in 2025, then jumped by 135.67% to $18.8 million in 2026.
  • The last three Amortization of Deferred Charges figures came in at $18.8 million (Q2 2026), -$52.7 million (Q4 2025), and $700000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Envista Holdings 4.06 Bn 2.98 Bn 390.10 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 18.80 Mn
Apr 3, 2026 18.80 Mn
Dec 31, 2025 -52.70 Mn
Dec 31, 2025 -52.70 Mn
Sep 26, 2025 700,000.00
Sep 26, 2025 700,000.00
Jun 27, 2025 100,000.00
Jun 27, 2025 100,000.00
Mar 28, 2025 18.80 Mn
Mar 28, 2025 18.80 Mn
Dec 31, 2024 -58.80 Mn
Dec 31, 2024 -58.80 Mn
Sep 27, 2024 100,000.00
Sep 27, 2024 100,000.00
Jun 28, 2024 100,000.00
Jun 28, 2024 100,000.00
Mar 29, 2024 1.20 Mn
Mar 29, 2024 1.20 Mn
Dec 31, 2023 -71.30 Mn
Dec 31, 2023 -71.30 Mn